Menu Search
Equities

Lepu Scientech Medical Technology Shanghai Co Ltd

2291:HKG.HZ

Lepu Scientech Medical Technology Shanghai Co Ltd

Actions
  • Price (HKD)13.76
  • Today's Change-2.08 / -13.13%
  • Shares traded526.00k
  • 1 Year change-50.50%
  • Beta--
Data delayed at least 15 minutes, as of Jun 03 2024 09:08 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Lepu Scientech Medical Technology Shanghai Co Ltd is a China-based investment holding company mainly engaged in the research and development, manufacturing and commercialization of interventional medical devices for structural heart disease. The Company operates primarily through two segments. The Occluder Business segment is mainly engaged in the research and development and sales of a series of interventional treatment series occluders for defective congenital heart disease. The Heart Valve Business segment is mainly engaged in the research and development of heart valve medical devices. The Company operates primarily in the domestic market.

  • Revenue in HKD (TTM)352.28m
  • Net income in HKD163.80m
  • Incorporated2021
  • Employees219.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.